IN-SILICO IDENTIFICATION OF POTENTIAL PROTEIN ARGININE DEIMINASE IV (PAD4) INHIBITORS
Protein Arginine Deiminase IV (PAD4) is a promising target for treating rheumatoid arthritis. Here, an in-silico screening was performed using PAD4 crystal structure against National Cancer Institute Diversity Set III compounds. Results obtained from the docking studies showed that the compounds have high affinity towards the protein.
openaire +1 more source
In the last decade, the association between the periodontitis and rheumatoid arthritis (RA) has been established, suggesting that oral microbiome plays a causal role by initiating this chronic autoimmune inflammatory disease of articulation. Both pathogenesis are similar in term of chronic inflammation, tissue breakdown and bone resorption.
Desclos-Theveniau, Marie +2 more
openaire +2 more sources
Targeting Peptidylarginine Deiminases in Neurons and Astrocytes in Central Nervous System Injury-Effects of Pan-PAD Inhibitor Cl-Amidine in an Oxygen-Glucose Deprivation Model of Ischaemia (OGD/R) and LPS Stimulation In Vitro. [PDF]
Ahmed D, Getting SJ, Ashioti M, Lange S.
europepmc +1 more source
Inhibition of <italic>Pseudomonas aeruginosa</italic> Biofilm Formation by Peptidyl-Arginine Deiminases 2 and 4. [PDF]
Baird R +7 more
europepmc +1 more source
Inhibition of PADI2-mediated vimentin citrullination alleviates silica-induced pulmonary fibrosis in mice. [PDF]
Jin F +12 more
europepmc +1 more source
Peptidylarginine Deiminases: An Overview of Recent Advances in Citrullination Research. [PDF]
Kijak-Boćkowska M +2 more
europepmc +1 more source
Novel Biomarker for Rheumatoid Arthritis: Serum Peptidylarginine Deiminase 4-Potentiating Activity in an Anti-Citrullinated Protein Antibody-Positive At-Risk Population. [PDF]
Kaminska M +8 more
europepmc +1 more source
Beyond PAD Inhibition: Emerging Avenues and Natural Products for Targeting Citrullination in Immune Diseases. [PDF]
Chen Q +7 more
europepmc +1 more source

